PUBLIC COMPANY
save$IMVTImmunovant, Inc.
$IMVT44.35-1.36%Durham, NC, USupdated 5h ago
community read0 votes
pipeline
2
marketed
0
phase 3
1
catalysts ytd
2
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
1Phase 21Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
earnings (2)
Insider activity
source: SEC Form 4open-market buys + sells
- Apr 23, 26SELLGirao Tiago· Chief Financial Officer−$763K↗
- Apr 23, 26SELLStout Jay S· Chief Technology Officer−$82K↗
- Apr 8, 26SELLGloria Melanie· Chief Operating Officer−$217K↗
- Apr 8, 26SELLStout Jay S· Chief Technology Officer−$214K↗
- Apr 8, 26SELLVan Tuyl Christopher· Chief Legal Officer−$128K↗
- Apr 8, 26SELLStout Jay S· Chief Technology Officer−$38K↗
- Apr 2, 26SELLVenker Eric· Chief Executive Officer−$308K↗
- Apr 2, 26SELLVenker Eric· Chief Executive Officer−$35K↗
- Mar 18, 26SELLVan Tuyl Christopher· Chief Legal Officer−$72K↗
- Feb 25, 26SELLGloria Melanie· Chief Operating Officer−$39K↗
- Feb 25, 26SELLGloria Melanie· Chief Operating Officer−$27K↗
- Feb 25, 26SELLGloria Melanie· Chief Operating Officer−$24K↗
routine RSU / option mechanics (6)
- Apr 7, 26grantPande Atul · director13,880 sh
- Apr 7, 26grantPande Atul · director7,061 sh
- Apr 7, 26grantBauer Jake · director13,880 sh
- Apr 7, 26grantBauer Jake · director7,061 sh
- Apr 7, 26grantSusman Robert Graham · director13,880 sh
- Apr 7, 26grantSusman Robert Graham · director7,061 sh
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 12m ago
Found something off?
comments(0)
5-min edit window · permanent after that